Cerebral vs Blueprint
Side-by-side comparison of AI visibility scores, market position, and capabilities
Online mental health platform for therapy, medication management, and psychiatry, San Francisco CA, raised $300M+. Serves anxiety, depression, ADHD, and insomnia.
About
Cerebral is a San Francisco, California-based online mental health company founded in 2020 that offers therapy, psychiatric evaluations, and medication management through a telehealth platform. The company raised over $300 million, achieving unicorn status in 2021 during a period of rapid growth, and serves patients with conditions including anxiety, depression, ADHD, insomnia, and bipolar disorder through a subscription-based access model.\n\nCerebral's model is designed to make psychiatric care and therapy more accessible than traditional in-person services by offering online intake, same-week appointments with licensed clinicians, electronic prescriptions, and medication delivery through pharmacy partners. The platform serves both self-pay and insurance-covered patients, having expanded insurance contracting significantly to reduce cost barriers. Cerebral employs a large clinician workforce of therapists and psychiatric nurse practitioners operating across most US states.\n\nThe company navigated a period of regulatory and reputational scrutiny in 2022–2023 related to prescribing practices and marketing claims, which led to leadership changes, workforce restructuring, and a strategic refocus on clinical quality and compliance. Cerebral has since invested in clinical governance infrastructure, stricter prescribing protocols, and transparent outcomes reporting. The company continues to compete with Talkspace, Done, and Done Global in the online psychiatry and therapy market, and has repositioned around a more clinically rigorous, insurance-first approach following the operational challenges of its hypergrowth phase.
Clinical measurement and therapy outcomes platform for mental health providers, Austin TX, raised $8M+. Automates outcome tracking and progress notes for therapists.
About
Blueprint is an Austin, Texas-based clinical technology company founded in 2018 that provides mental health providers with a measurement-based care platform designed to automate outcomes tracking, streamline progress note documentation, and improve the quality and consistency of mental health treatment. The company has raised over $8 million and serves thousands of therapists and group practices seeking to implement structured clinical measurement without significant workflow disruption.\n\nBlueprint's platform automates the collection of validated clinical questionnaires (such as PHQ-9, GAD-7, and PCL-5) before or between sessions, presents clinicians with outcome trend visualizations at the point of care, and generates draft progress notes based on session data. The AI-assisted note generation feature is particularly valued by clinicians who spend significant time on documentation after sessions, with Blueprint reducing note completion time while improving clinical documentation quality and compliance.\n\nThe company distributes through direct sales to individual therapists and group practices, and is expanding partnerships with group practice management platforms and EHR vendors to embed its measurement capabilities into existing clinical workflows. Blueprint competes with Greenspace Health and Osmind in the measurement-based care space, and with Nabla and Heidi Health in the AI-assisted clinical documentation market. The intersection of outcomes accountability and administrative relief positions Blueprint as both a quality improvement tool and a therapist burnout reduction solution.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.